Investigational Drug Information for Fluzoparib
✉ Email this page to a colleague
What is the development status for investigational drug Fluzoparib?
Fluzoparib is an investigational drug.
There have been 56 clinical trials for Fluzoparib.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 19th 2020.
The most common disease conditions in clinical trials are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, and Breast Neoplasms. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Fudan University, and Beijing Cancer Hospital.
There are two US patents protecting this investigational drug and twenty-one international patents.
Summary for Fluzoparib
| US Patents | 2 |
| International Patents | 21 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 34 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 1 (2020-08-19) |
| Vendors | 27 |
Recent Clinical Trials for Fluzoparib
| Title | Sponsor | Phase |
|---|---|---|
| Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer | The First Affiliated Hospital of Xiamen University | Phase 3 |
| Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi | Guangxi Medical University | Phase 2 |
| A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors | Chongqing University Cancer Hospital | Phase 2 |
Clinical Trial Summary for Fluzoparib
Top disease conditions for Fluzoparib
Top clinical trial sponsors for Fluzoparib
US Patents for Fluzoparib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Fluzoparib | ⤷ Subscribe | Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof | Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) | ⤷ Subscribe |
| Fluzoparib | ⤷ Subscribe | Methods of using phthalazinone ketone derivatives | Jiangsu Hansoh Pharmaceutical Co., Ltd. (Lianyungang, Jiangsu, CN) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Fluzoparib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Fluzoparib | Australia | AU2011288876 | 2030-08-09 | ⤷ Subscribe |
| Fluzoparib | Brazil | BR112013002220 | 2030-08-09 | ⤷ Subscribe |
| Fluzoparib | Canada | CA2806324 | 2030-08-09 | ⤷ Subscribe |
| Fluzoparib | China | CN102372716 | 2030-08-09 | ⤷ Subscribe |
| Fluzoparib | China | CN102686591 | 2030-08-09 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
